The RTW Podcast

The 3x Survivor: CEO of Her Own Body: Amanda Rice on Patient Self-Advocacy and the Fight for Fertility Preservation Coverage

Innovation is the Best Medicine

The American healthcare system faces a critical tension between rapid medical innovation and an intensifying affordability crisis. The "drug innovation treadmill" defines this sector, where companies must continuously innovate to replace revenue lost to forced generic substitution after patents expire. While this model...

Redefining the Weight Loss Revolution Beyond GLP1s: Influential Voices in the New Food Economy

Sustainable weight loss relies on consistent, incremental lifestyle changes rather than temporary hacks or restrictive diets. Hunter Stoler, a health influencer and certified coach, emphasizes that diet accounts for 90% of weight management, advocating for nutrient-dense, whole foods over processed alternatives. His tr...

Psilocybin on the Verge: Treating Depression at Compass Pathways

Psilocybin: Counterculture to Cutting-Edge Psychiatry

ASCO: The Biggest Event in Oncology

Women's Health: An Investing Whitespace

Gene Editing: From CRISPR to Curative Medicine

Biotech’s Next Era: Innovation and Commercialization

The Split Vote: UroGen and the FDA

14 Months to Treatment: Breaking Records in Rare Disease Therapy

Losing Sleep and Lives: Matthew Walker on the Global Sleep Epidemic

From drop to double: Akero’s surging stock

Ditching Delay: GH001’s Instant Impact on Depression

GH Research's efforts to develop novel treatments for treatment-resistant depression are examined, focusing on their drug GH001. GH Research CEO Villy Valcheva explains that GH001 aims to provide ultra-rapid remission with infrequent administrations, distinguishing it from Spravato with its complex induction system. A ...

Changing Minds: Psychedelics as Legitimate Medicine

The discussion centers on the history, challenges, and future of psychedelic drugs in treating mental health disorders, particularly treatment-resistant depression. It traces the evolution of antidepressants from serendipitous discoveries like MAO inhibitors to the stagnation in innovation following the SSRI boom. The ...

Inside the clinic: GLP-1s with Dr. Rekha B. Kumar

The $1 trillion GLP-1 revolution with Rod Wong

Revolutionizing RNA therapeutics - Avidity Biosciences

The power of partnership – Prometheus Biosciences